Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized maintenance vinflunine study in advanced or metastatic urothelial transitional cell carcinoma after first-line cisplatin + gemcitabine benefit
2011-001271-39Phase 2Completed
- Sponsor
- SOGUG
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in transitional cell carcinoma (TCC) comparing Vinflunine maintenance + best supportive care with Best supportive care control (2 arms). Primary endpoint: Progression-free survival. Started May 2011; status: completed.
02
Drugs
vinflunine
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on 2011-001271-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001271-39.